Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Leukemia, Myeloid × Mitoxantrone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 25 Leukemia 9 Precursor Cell Lymphoblastic Leukemia-Lymphoma 8 Congenital Abnormalities 8 Leukemia, Monocytic, Acute 7 Leukemia, Myelomonocytic, Acute 6 Leukemia, Megakaryoblastic, Acute 6 Leukemia, Erythroblastic, Acute 6 Recurrence 4 Myelodysplastic Syndromes 4 Prostatic Neoplasms 2 Neoplasms 2 Leukemia, Eosinophilic, Acute 2 Leukemia, Basophilic, Acute 2 Sarcoma, Myeloid 1 Ovarian Neoplasms 1 Neoplasm Metastasis 1 Lymphoma, T-Cell 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myeloid 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia, Biphenotypic, Acute 1 Carcinoma, Ovarian Epithelial 1 Anemia, Refractory, with Excess of Blasts 1

Interventions

venetoclax 5 Cytarabine 4 Azacitidine 4 fludarabine 3 aldesleukin 2 RO6839921 2 Methotrexate 2 Interleukin-2 2 Granulocyte Colony-Stimulating Factor 2 Etoposide 2 Decitabine 2 Dasatinib 2 zileuton 1 thymoglobulin 1 spartalizumab 1 sabatolimab 1 quizartinib 1 pulrodemstat besilate 1 posaconazole 1 plerixafor 1 gilteritinib 1 fludarabine phosphate 1 etoposide phosphate 1 emvododstat 1 daratumumab 1 blinatumomab 1 Sorafenib 1 Sirolimus 1 Panobinostat 1 N-((5-bromo-2-thienyl)sulfonyl)-2,4-dichlorobenzamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00780104 2019-07-12

UPCC 02407

Abramson Cancer Center at Penn Medicine

Phase 1 Completed

Other hematologic neoplasm

Leukemia, Leukemia, Myeloid

Data powered by HemOnc (CC BY 4.0) Colophon ⚡